LG Life Sciences Ltd (068870) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

LG Life Sciences Ltd Company Snapshot

Business Description:

LG Life Sciences Ltd operates in the Pharmaceutical preparations sector. LG Life Sciences, Ltd is a Korea-based company engaged in the pharmaceuticals and fine chemicals industries. The Company's pharmaceutical products consist of growth hormone substances, arthritis remedies, hypertension remedies, hepatitis B vaccines, anti-infective drugs, cardiovascular remedies, hyaluronic acid products and others, as well as animal drugs, such as milk production stimulants for cows. Its fine chemical products consist of ingredients for plant protection, including insecticides, fungicides and herbicides, and pharmaceutical ingredients. In our complete report available for purchase the company is compared to: Handok Pharmaceuticals Co., Ltd., Boryung Pharmaceutical Company Limited and Jeil Pharmaceutical Company Limited.

LG Life Sciences Ltd

Stock Data:

Recent Stock Performance:

Current Price (2/10/2012): 36,850
(Figures in Korean Won)

1 Week	-2.3%	13 Weeks	4.4%

4 Weeks	1.9%	52 Weeks	-18.5%

LG Life Sciences Ltd Key Data:

Ticker:	068870	Country:	KOREA (SOUTH)

Exchanges:	SEO	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Medical, Surgical & Dental Suppliers

2010 Sales	334,341,285,000 (Year Ending Jan 2011).	Employees:	1,194

Currency:	Korean Won	Market Cap:	610,861,639,300

Fiscal Yr Ends:	December	Shares Outstanding:	16,576,978

Share Type:	Common	Closely Held Shares:	5,128,256

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.